MAURITIUS – Imperial, through its Market Access Healthcare business, has made a strategic investment in Vicore Health, an emerging Mauritian based health product industry service and technology provider.

Vicore health specializes in Pharmacovigilance, Governance, Regulatory and Medical Affairs solutions. This investment will give Imperial a 25% stake in the business.

Imperial Holdings Ltd. operates as an investment holding company with interest in food, healthcare, housing, transport, insurance, data management, and blockchain industries.

In looking to execute on our purpose of connecting Africa and the world and improving people’s lives with access to quality products & services, we need to have access to the markets of Africa and this often starts with an understanding of the regulatory environment and how we operate in these markets, all having a sometimes different set of rules and requirements. This is where our work with Vicore Health and their team begins,” says Johan Truter, CEO of the Market Access business at Imperial.

Vicore Health has vast experience through their internal and external expert network, allowing flexibility, scalability and convenience, and gives Imperial peace of mind that the Group is working within the correct confines of applicable regulations and healthcare requirements.

The company’s main customers include pharmaceutical, medical device and complementary medicine manufacturers, and marketing authorisation holders across Africa and emerging markets.

The business offers products and services across an array of different models to suit customers’ needs and can vary from fully managed services with supporting technology platforms to ad hoc workload relief for in-house functions.

Our Market Access Healthcare business is designed to deliver a range of services in a very highly regulated sector, particularly when it comes to the supply and promotion of medicines for human use,” David Pritchard, Imperial’s Executive Vice President of the Market Access Healthcare business, said.

“As Vicore Health, we share Imperial’s purpose, and want to ensure our patients and consumers on the continent get access to the quality products and services they need. This investment further entrenches the longstanding strategic partnership between the two organisations whilst also accelerating Vicore Health’s mission,” says Dr. Emile Malan, Managing Director of Vicore Health.

This deal follows a similar deal sealed by Imperial late last year, where the company acquired a 49 percent shareholding in Pharmafrique (trading as Kiara Health). Kiara Health is an African pharmaceutical manufacturing and healthcare services company based in Johannesburg.

The investment was in line with Imperial’s strategy to backward integrate into contract manufacturing as part of our market access service to multinationals on the continent.

Would you like to get regular updates of such news articles? Subscribe to our HealthCare Africa News, email newsletters, which provide the latest news insights from Africa and the World’s health, pharma and biotech industry. SUBSCRIBE HERE